PLx Pharma Inc (PLXP)

NASDAQ
0.35
-0.01(-2.91%)
After Hours
0.36
+0.01(+2.00%)
- Real-time Data
  • Volume:
    104,500
  • Day's Range:
    0.34 - 0.37
  • 52 wk Range:
    0.30 - 10.53

PLXP Overview

Prev. Close
0.36
Day's Range
0.34-0.37
Revenue
4.54M
Open
0.36
52 wk Range
0.3-10.53
EPS
-0.99
Volume
104,500
Market Cap
10.2M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
302,893
P/E Ratio
-0.364
Beta
3.73
1-Year Change
-96.46%
Shares Outstanding
29,137,692
Next Earnings Date
Mar 10, 2023
What is your sentiment on PLx Pharma?
or
Market is currently closed. Voting is open during market hours.

PLx Pharma Inc News

PLx Pharma Inc Analysis

PLx Pharma Inc Company Profile

PLx Pharma Inc Company Profile

Employees
18

PLx Pharma Inc. is a commercial-stage drug delivery platform technology company, which is focused on its clinically validated and patent-protected PLxGuard technology. The Company has two commercialized products, VAZALORE 81 milligram (mg) and VAZALORE 325 mg, which are liquid-filled aspirin capsules for over the counter (OTC) distribution. The Company markets VAZALORE to the healthcare professional and the consumer through several sales and marketing channels. Its product pipeline also includes other oral NSAIDs using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, for pain and inflammation in Phase I clinical stage. PLxGuard drug delivery platform employs a pH-dependent release mechanism that relies on association of lipidic excipients with APIs for targeted release in the GI tract.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellSellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Revenue growth bout to explode.
    0
    • Short this dog ******!!
      1
      • good stock for big money
        2